Crestor ruling by FDA, AstraZeneca stocks surge

Shares of AstraZeneca, maker of cholesterol drug Crestor, surged more than 4 per cent following the Food and Drug Administration""™s (FDA) ruling that the muscle damage risk posed by the drug is no more than that in the case of other cholesterol-lowering

Continue to Crestor ruling by FDA, AstraZeneca stocks surge on Misc sources.

Guarantee finance is a leading newssite providing news about stocks, markets, finance, mortgage rates, refinancing, home loans, equity, consolidation and currencies. Click below for more finance news.
Guarantee finance